Listen to the article 2 min This audio is generated automatically. Please let us know if you have any comments.
Taiwan-based Bora Pharmaceuticals has acquired a sterile manufacturing facility from Emergent BioSolutions, according to a Press release of June 20.
The 87,000-square-foot facility in Camden, Maryland, will feature sterile injectable manufacturing services and will feature four filling lines including lyophilization, vial filling and prefilled syringe filling.
The $30 million deal includes the transfer of assets, equipment and Emergent’s established workforce of approximately 350 employees.
The transaction is expected to close in the third quarter and is subject to customary closing conditions. according to Emergent.
For Bora, the acquisition of the Camden facilities represents part of its expansion strategy in the US.
“Bora has ambitious plans to enhance the newly acquired facilities, and all staff currently based at the Camden site will have the opportunity to remain on site and become part of the Bora team,” the company said.
The acquisition also supports Bora’s expansion into sterile pharmaceutical manufacturing and complements its biologics manufacturing and development services, according to the news release.
The Camden acquisition follows Bora Pharmaceutical’s purchase of the Minnesota-based company Upsher-Smith Laboratories for $210 million earlier this year in an effort to strengthen its presence in North America.
Upsher-Smith Laboratories is a generic manufacturer with facilities in Plymouth and Maple Grove, Minnesota, producing a variety of drug dosage forms including oral solids, powders, liquids and packages.
Bora Pharmaceuticals now has two facilities in the United States, five in Taiwan and one in Canada, according to its website.
Emergent’s sale of its Camden facility follows its announcement in May that it would also close its Baltimore and Rockville facilities and lay off 300 workers.
The Maryland-based pharmaceutical maker is in the midst of restructuring operations with plans to save up to $80 million.
Keynote USA
For the Latest Local News, Follow Keynote USA Local on Twitter.